Back
Esperion Therapeutics Stock Price Chart
Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
14
ESPR
Esperion Therapeutics
Last Price:
$1.70
Seasonality Move:
3.95%
7 Day Trial
ALL ACCESS PASS
$
7
Apple just traded your privacy for $20 Billion
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESPR is experiencing slight buying pressure.
Esperion Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.58 | Buy |
| 20-day SMA: | 1.64 | Buy |
| 50-day SMA: | 1.86 | Sell |
| 200-day SMA: | 2.13 | Sell |
| 8-day EMA: | 0.66 | Buy |
| 20-day EMA: | 0.3 | Buy |
| 50-day EMA: | 0.13 | Buy |
| 200-day EMA: | 0.03 | Buy |
Esperion Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 49.77 | Sell |
| Chaikin Money Flow: | 2412873 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.56 - 1.82) | Sell |
| Bollinger Bands (100): | (1.7 - 2.6) | Sell |
Esperion Therapeutics Technical Analysis
| Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Esperion Therapeutics Stock
Is Esperion Therapeutics Stock a Buy?
-
Esperion Therapeutics share price is 1.69 while ESPR 8-day simple moving average is 1.58, which is a Buy signal.
-
The stock price of ESPR is 1.69 while Esperion Therapeutics 20-day SMA is 1.64, which makes it a Buy.
-
Esperion Therapeutics 50-day simple moving average is 1.86 while ESPR share price is 1.69, making it a Sell technically.
-
ESPR stock price is 1.69 and Esperion Therapeutics 200-day simple moving average is 2.13, creating a Sell signal.
ESPR Technical Analysis vs Fundamental Analysis
Sell
14
Esperion Therapeutics (ESPR)
is a Sell
Is Esperion Therapeutics a Buy or a Sell?
-
Esperion Therapeutics stock is rated a SellThe current Esperion Therapeutics [ESPR] share price is $1.69. The Score for ESPR is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
Esperion Therapeutics Stock Info
Market Cap:
334.4M
Price in USD:
1.69
Share Volume:
5M
Esperion Therapeutics 52-Week Range
52-Week High:
3.94
52-Week Low:
1.47
Sell
14
Esperion Therapeutics (ESPR)
is a Sell
Esperion Therapeutics Share Price Forecast
-
What is the Esperion Therapeutics stock price today?The Esperion Therapeutics stock price is 1.69 USD today.
-
Will ESPR stock go up or go down?Esperion Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Esperion Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Esperion Therapeutics is overvalued.
Is Esperion Therapeutics Stock a Buy?
-
Esperion Therapeutics share price is 1.69 while ESPR 8-day exponential moving average is 0.66, which is a Buy signal.
-
The stock price of ESPR is 1.69 while Esperion Therapeutics 20-day EMA is 0.30, which makes it a Buy.
-
Esperion Therapeutics 50-day exponential moving average is 0.13 while ESPR share price is 1.69, making it a Buy technically.
-
ESPR stock price is 1.69 and Esperion Therapeutics 200-day simple moving average is 0.03, creating a Buy signal.
Fundamental Analysis of Esperion Therapeutics
Is Esperion Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and a decrease next year of $0.19 per share.
Technical Analysis of Esperion Therapeutics
Should I short Esperion Therapeutics stock?
-
ESPR Moving Average Covergence Divergence (MACD) indicator is 0.23, suggesting Esperion Therapeutics is a Buy
-
Esperion Therapeutics Relative Strength Index (RSI) is 49.77, which suggest Esperion Therapeutics is oversold
-
The Bollinger Bands (25) for Esperion Therapeutics is (1.56 - 1.82), which suggest Esperion Therapeutics is a Sell
-
The Bollinger Bands (100) for Esperion Therapeutics is (1.7 - 2.6), which suggest Esperion Therapeutics is a Sell
* Esperion Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.